Grassroots Party Branch Convenes Democratic Life Meeting
Release time:
2021-03-22
2020 , and party members commented on the work and style of the party branch committee. Xu Junxiong also gave a special party lesson for all party members under the title of "carrying forward the spirit of" three cattle "and writing a new answer sheet of the times. 2021 is the 15th anniversary of the founding of the Communist Party of China 100#, the first year of the 14th Five-Year Plan, and the beginning of a new journey to build a modern socialist country in an all-round way. At the beginning of the new year, General Secretary Xi Jinping endowed Ruziniu with the profound ideological connotation of "serving the people", pioneering cattle with "innovative development", and old scalpers with "hard work", and twice encouraged the whole party, the whole army and the people of all ethnic groups throughout the country to inspire the new journey with the "three bull spirit. All the party members attending the meeting expressed that they would continue to inherit and carry forward the spirit of "three cattle" and show new atmosphere and new achievements on the new journey. At the meeting, all party members also conscientiously studied and implemented Xi Jinping's thinking on socialism with Chinese characteristics in the new era, conscientiously found gaps and deficiencies in the aspects of performing their duties, taking responsibility, doing solid work, and abiding by rules and regulations, and carried out criticism and self-criticism. At the
democratic life meeting of the peak health party branch, Chen daiyou, secretary of the peak health party branch, gave a party lesson on the theme of "keeping close to the production and operation center and giving full play to the exemplary role of advanced models and party members. He focused on "how to give full play to the advanced role of enterprises and exemplary role of party members" in combination with the nine major global macroeconomic prospects in 2021 , the eight major economic phenomena and trends in 2021 , some work objectives and some key work contents of the national two sessions in 2021 , and further enhanced the political consciousness, ideological consciousness and action consciousness of party members in the branch. Chen Daiyou also summarized the work of the Party branch in 2020 . The participating party members conducted democratic evaluation on the branch team, put forward opinions and suggestions, and conducted democratic evaluation on the basis of the individual summary of the party members, and adopted personal self-evaluation and mutual evaluation of the party members. The way to carry out criticism and self-criticism, find out their own gaps and shortcomings.
3 September 12 , 15 , 16 , the three party branches of Jinhua pharmaceutical company, administration, operation and storage, successively held branch party member meetings. all party members studied and implemented the group party Committee document 1 , carefully reviewed the branch work, and carried out criticism and self-criticism according to their own situation. Wu Weisheng, secretary of the party branch of the pharmaceutical company, said that carrying out democratic life meetings and democratic appraisal of party members is an important part of the political life of party members. In the current situation of frequent policies in the field of pharmaceutical circulation and difficulties in business operations, the development of party members' democratic life meetings and democratic evaluation of party members can enable all party members to lead all employees to unify their thinking, promote style, enhance unity, and improve their own strength The ability to solve problems and contradictions, earnestly implement the company's various measures, and enable the company to develop steadily and sustainably.
(Zhang Zhengbo Zhou Guangliang Fan Tufa Sheng Da)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page